Periodontal disease and cardiovascular disease: what the evidence actually shows
A close reading of the American Heart Association's own statements shows a real, replicated association and an honest, unresolved gap on causation.
For more than two decades, patients have heard some version of the claim that gum disease causes heart disease. The claim is popular in dental marketing and in general wellness media. It is also not what the cardiology literature says, and the distinction matters more than it might seem, because overclaiming a link this consequential erodes trust in the parts of the connection that are genuinely well established.
What the association studies show
Multiple large observational studies, spanning different populations and decades, have found that people with periodontal disease have a higher incidence of atherosclerotic cardiovascular disease (ASCVD) than people without it, independent of shared risk factors like smoking, age, and diabetes. This pattern has held up across epidemiological cohorts and, more recently, in Mendelian randomization studies that attempt to isolate genetic proxies for periodontal disease from confounding lifestyle factors.
The American Heart Association has now issued two scientific statements on this question. The first, published in Circulation in 2012 and led by Peter B. Lockhart, concluded that "observational studies support an association between periodontal disease and atherosclerotic vascular disease independent of known risk factors" but explicitly stated that these studies "do not, however, support a causative relationship." The statement also noted that although periodontal interventions reduced inflammation in short-term studies, "there is no evidence that they prevent ASVD or modify its outcomes."
Thirteen years later, the AHA revisited the question with an updated statement, published online in Circulation on December 16, 2025 and chaired by Andrew H. Tran. The update incorporated newer evidence, including Mendelian randomization data and studies on inflammatory cytokines and vascular measures, and extended the association to a broader set of outcomes: heart attack, stroke, atrial fibrillation, heart failure, and cardiometabolic conditions. The verdict on causation, however, did not change. The statement is direct about it: "Although periodontal disease clearly contributes to chronic inflammation that is associated with ASCVD, a cause-and-effect relationship has not been confirmed." It adds, without qualification, "There is also no direct evidence that periodontal treatment will help prevent cardiovascular disease."
That is thirteen years, two full scientific statements, and a meaningful expansion of the evidence base, without a change in the bottom-line causal verdict. This is not a field stuck in place. It is a field that keeps finding the same shape of relationship: real, replicated, and not yet proven causal.
The inflammation mechanism hypotheses
The proposed mechanisms fall into two general categories. The first is direct: periodontal pathogens, including Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans, can enter the bloodstream from periodontal pockets during normal activities like chewing and brushing, not only during dental procedures. Bacterial components such as lipopolysaccharides are proposed to trigger endothelial dysfunction and vascular inflammation directly at the arterial wall.
The second is indirect and systemic: periodontal disease is associated with chronic low-grade elevation of inflammatory markers, including C-reactive protein, interleukin-6, and tumor necrosis factor-alpha, alongside reduced levels of anti-inflammatory mediators like adiponectin. Because chronic systemic inflammation is independently implicated in atherosclerosis, this pathway does not require oral bacteria to reach the artery at all. A third, more speculative mechanism involves molecular mimicry, in which immune responses to bacterial heat shock proteins cross-react with human vascular tissue and contribute to endothelial injury.
These are plausible, biologically grounded hypotheses. None of them, individually or together, has been shown to account for a causal effect of periodontal disease on cardiovascular outcomes in humans. Plausibility is not proof.
What intervention trials actually show
The clearest test of causation is not an association study but an intervention trial: treat periodontal disease in one group, don't in another, and see whether cardiovascular events differ. This is where the evidence is thinnest.
The most relevant such trial is PAVE (Periodontitis and Vascular Events), which enrolled patients with a prior history of ASCVD and randomized them to periodontal scaling and root planing versus community care. The trial found no significant difference in cardiovascular event incidence between groups, but it was a small pilot (151 vs. 152 patients) with variable follow-up and high loss to follow-up, and its authors and later reviewers describe the result as inconclusive rather than negative.
A broader look at the intervention literature reaches a consistent conclusion: randomized trials show that periodontal treatment can reduce surrogate markers of cardiovascular risk, such as C-reactive protein, endothelial function measures, and lipid profiles, but no randomized controlled trial to date has demonstrated that periodontal therapy prevents hard cardiovascular endpoints such as myocardial infarction or stroke. As one recent review of the intervention literature put it, there is "sufficient evidence to conclude that periodontal intervention reduces the surrogate markers of ASCVD but insufficient evidence to conclude that it prevents ASCVD events." Only two RCTs with adequate follow-up (over one year) exist, and neither showed clear event prevention.
Surrogate markers moving in the right direction is a meaningful finding. It is not the same as proving that treating gum disease prevents heart attacks, and no honest reading of the trial record currently supports that stronger claim.
What this means in practice
The honest summary is this: periodontal disease and cardiovascular disease travel together more often than chance would predict, the biological story for why is plausible on multiple fronts, and good oral hygiene and periodontal care remain worthwhile for their own sake and for general health. What the evidence does not yet support is a claim that treating your gums will prevent a heart attack, or that gum disease should be treated as a cardiac risk factor on par with smoking or hypertension. The AHA's own position, restated in 2025 after re-reviewing the field, is that people with cardiovascular risk factors "may benefit from regular dental screenings and targeted periodontal care," which is a modest, appropriately hedged clinical suggestion, not a causal claim. Patients navigating cardiac procedures where dental clearance is now a real gatekeeping step, such as valve replacement or transplant workups, can check what Medicare will actually cover at checkmydenial.com, and dental practices building clearance protocols for these patients can see the standard of care at predentalcheck.com.
Sources
- Lockhart PB, Bolger AF, Papapanou PN, et al. "Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association? A scientific statement from the American Heart Association." Circulation. 2012. https://pubmed.ncbi.nlm.nih.gov/22514251/
- Tran AH, Zaidi AH, Bolger AF, et al. "Periodontal Disease and Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association." Circulation, published online December 16, 2025. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001390
- American Heart Association Newsroom. "Gum disease may be linked to plaque buildup in arteries, higher risk of major CVD events." December 16, 2025. https://newsroom.heart.org/news/gum-disease-may-be-linked-to-plaque-buildup-in-arteries-higher-risk-of-major-cvd-events
- "Periodontitis and atherosclerotic cardiovascular disease" (review discussing the PAVE trial and intervention evidence). PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC11612374/